vimarsana.com
Home
Live Updates
Foghorn Therapeutics to Participate at the H.C. Wainwright B
Foghorn Therapeutics to Participate at the H.C. Wainwright B
Foghorn Therapeutics to Participate at the H.C. Wainwright BioConnect Conference
CAMBRIDGE, Mass., Jan. 07, 2022 -- Foghorn® Therapeutics Inc. , a company pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies... | January 7, 2022
Related Keywords
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Hc Wainwright Bioconnect ,
Hans Vitzthum ,
Gregory Kelley ,
Therapeutics Inc ,
Foghorn Therapeutics Inc ,
Nasdaq ,
Globenewswire Inc ,
Bioconnect Conference ,
Gene Traffic Control Platform ,
Gene Traffic ,
Sci Advisors ,
Foghorn Therapeutics Inc Stock Exchange ,
News ,
Information ,
Press Release ,
022 ,
Herapeutics ,
Company ,
Ioneering ,
The ,
Discovery ,
End ,
Development ,
F ,
Few ,
Glass ,
Medicines ,
Targeting ,
Genetically ,
Etermined Fhtx Us3441741077 ,